AltMountain

Inovexus Early Stage Fund Master Entity, LP - B1

Seattle, WA · CIK 1961773
506(c)
Status: no Form D since Jan 2023. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Inovexus Early Stage Fund Master Entity, LP - B1 is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Jan 11, 2023, it has sold $142,500 of interests to 11 investors since its first sale in Jan 2023. The minimum investment it accepts from an outside investor is $6,250. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Ltd. Belltower Fund Group; LLC Fund GP.

Total raised
$142,500Cumulative sales reported on Form D
Investors
11
First sale
Jan 2, 2023
Minimum investment
$6,250
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(c)May advertise; investors must be verified as accredited
Key people and entities
Ltd. Belltower Fund Group; LLC Fund GP
Latest Form D
Jan 11, 2023

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Related vehicles with the same name (7)

VehicleTotal raisedInvestorsLatest Form D
Inovexus Early Stage Fund Master Entity, LP - B2$195,20217Jun 13, 2023
Inovexus Early Stage Fund Master Entity, LP - B1 (this page)$142,50011Jan 11, 2023
Inovexus Early Stage Fund Master Entity, LP - A3$137,49512Jul 13, 2022
Inovexus Early Stage Fund Master Entity, LP - A4$131,22012Oct 7, 2022
Inovexus Early Stage Fund Master Entity, LP - B3$89,75317Mar 20, 2024
Inovexus Early Stage Fund Master Entity, LP - A1$25,0004Jan 26, 2022
Inovexus Early Stage Fund Master Entity, LP - A2$25,0001Apr 18, 2022

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 7 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.

Questions about Inovexus Early Stage Fund Master Entity, LP - B1

What is the minimum investment for Inovexus Early Stage Fund Master Entity, LP - B1?

According to its latest Form D, filed Jan 11, 2023, the minimum investment Inovexus Early Stage Fund Master Entity, LP - B1 accepts from an outside investor is $6,250.

Who can invest in Inovexus Early Stage Fund Master Entity, LP - B1?

Inovexus Early Stage Fund Master Entity, LP - B1 is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.

How much has Inovexus Early Stage Fund Master Entity, LP - B1 raised?

Inovexus Early Stage Fund Master Entity, LP - B1 reports $142,500 sold from 11 investors on its Form D filed Jan 11, 2023. This is cumulative sales since the offering began, not current assets or performance.

Where is Inovexus Early Stage Fund Master Entity, LP - B1 based?

Inovexus Early Stage Fund Master Entity, LP - B1 is based in Seattle, Washington.

When did Inovexus Early Stage Fund Master Entity, LP - B1 launch?

Inovexus Early Stage Fund Master Entity, LP - B1 reports its first sale in Jan 2023.

Size compared with every venture capital fund

Raised more than 38% of the 5,428 venture capital funds based in Washington, and more than 23% of all 14,877 that report sales.

More venture capital funds in Seattle